Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Clear Creek Bio doses first patient in Covid-19 trial with brequinar

pharmaceutical-business-reviewSeptember 03, 2020

Tag: Clear Creek Bio , brequinar , COVID-19

PharmaSources Customer Service